In this era of global technology transformation, software companies have had their fair share of traction, and rightly so!
On February 6, Evercore ISI raised its target price on Pinnacle Financial by 0.9% to $116 (from $115) and retained its ...
On January 20, Leonid Timashev of RBC Capital maintained an Outperform rating on Legend Biotech (NASDAQ:LEGN) and set a $66 ...
On February 12, Qize Ding from Rothschild & Co Redburn downgraded the rating on Arcellx Incorporated (NASDAQ:ACLX) from Buy ...
Sands Capital Technology Innovators Fund stated the following regarding Taiwan Semiconductor Manufacturing Company Limited ...
On January 23, Cantor Fitzgerald maintained its Overweight rating on Vaxcyte Incorporated (NASDAQ:PCVX), highlighting ...
On January 29, Danielle Brill from Truist Financial raised her price target on Centessa Pharmaceuticals (NASDAQ:CNTA) from $33 to $38 and assigned a Buy rating to the stock.
As of the February 12 closing, Dyne Therapeutics (NASDAQ:DYN) held a strongly bullish consensus view. Of the 9 analysts ...
On February 9, JPMorgan analyst Andrew Dietrich raised his target price on Huntington Bancshares by 5.0% to $21 (from $20) ...
On February 4, UBS slightly increased its target price on SouthState Bank (SSB) to $121 (from $120) and reiterated its Buy ...
On January 20, the price target on Soleno Therapeutics (NASDAQ:SLNO) was increased from $110 to $120 by Ram Selvaraju from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results